Skip Navigation

Journal of Tropical Pediatrics 1990 36(4):148-155; doi:10.1093/tropej/36.4.148
© 1990 by Oxford University Press
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by El-Hazmi, M. A. F.
Right arrow Articles by Warsy, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by El-Hazmi, M. A. F.
Right arrow Articles by Warsy, A. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

research-article

The Features of Sickle Cell Disease in Saudi Children

M. A. F. El-Hazmi, BSc(Hons), PhD(Cantab), MBBChir(Cantab), MRCPath, FACB*, H. M. Bahakim, MD*, A. M. Al-Swailem, FACHARTZ, PhD** and A. S. Warsy, PhD, FACB***

*College of Medicine & King Khalid University Hospital, King Saud University Riyadh, Saudi Arabia
**Children's Central Hospital, Ministry of Health Riyadh, Saudi Arabia
***Centre for Science and Medical Studies for Girls, College of Science, King Saud University Riyadh, Saudi Arabia

Correspondence: Prof. Mohsen A. F. El-Hazmi, Medical Biochemistry Department (30), College of Medicine & King Khalid University Hospital, P.O. Box 2925, Riyadh 11461, Saudi Arabia.

Using a prospective and retrospective approach, the features of sickle cell disease (SCD) were investigated in 137 SCD children from the south-western region of Saudi Arabia.

The patients were followed for a period of 2–5 years, during which period the severity of the disease was assessed and a ‘severity index’, was calculated for individual patients.

The patients with SCD were classified into five groups based on the absence of thalassaemia (sickle cell anaemia, SCA), presence of ß°-thalassaemia (HbS/ß°-thalassaemia), SCA with {alpha}-thalassaemia.2 [heterozygotes (–{alpha}/{alpha}{alpha}) or homozygotes (–{alpha}/{alpha})] and S/ß°-thaalassaemia with {alpha}-thalassaemia. The results showed a high prevalence of associated {alpha}-thalassaemia and variable levels of HbF in these patients. SCA patients with associated {alpha}-thalassaemia (–{alpha}/-{alpha}) and S/ß°-thalissaemia patients with one {alpha}-gene deletion had the highest values for haematological parameters and lowest values of red cell indices. No specific difference could be identified in the clinical manifestations hi the different groups with the exception that long bone crisis and hand-foot syndrome were not encountered hi patients with associated {alpha}-thalassaemia. The frequency of hepatomegaly and splenomegaly was also lower in this group.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 The Journal of the Royal Society for the Promotion of HealthHome page
R.K. Pejaver, F. Ahmad, and H. Bedawi
Sickle cell anaemia in Saudi-Arabian children
The Journal of the Royal Society for the Promotion of Health, June 1, 1995; 115(3): 156 - 158.
[Abstract]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.